Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
Sidley Advises on Galaxy Digital’s US$500 Million At-the-Market Equity ProgramMay 14, 2026Sidley Ranked in Benchmark Litigation Asia-Pacific 2026May 13, 2026PRA Proposes Tighter Capital and Risk Framework for Funded ReinsuranceMay 13, 2026Scientific Research and the GDPR: EDPB Issues Long-Awaited GuidelinesMay 12, 2026Sidley Represents Private Equity at Goldman Sachs Alternatives in the Acquisition of FGI WorldwideMay 12, 2026When “The Devil Made Me Do It” Is Not a Defense: Lessons in AI Governance and Organizational Oversight from an SDNY DecisionMay 11, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory